491 related articles for article (PubMed ID: 392179)
1. [Vitamin D metabolism in kidney insufficiency: disorders of an endocrine regulatory zone].
Ritz E; Kreusser W; Boland R; Bommer J
Klin Wochenschr; 1979 Oct; 57(19):1053-9. PubMed ID: 392179
[TBL] [Abstract][Full Text] [Related]
2. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
Brandi L
Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
[TBL] [Abstract][Full Text] [Related]
3. Vitamin D and type II sodium-dependent phosphate cotransporters.
Kido S; Kaneko I; Tatsumi S; Segawa H; Miyamoto K
Contrib Nephrol; 2013; 180():86-97. PubMed ID: 23652552
[TBL] [Abstract][Full Text] [Related]
4. Vitamin D metabolites and bone mineralization in man.
Bordier P; Rasmussen H; Marie P; Miravet L; Gueris J; Ryckwaert A
J Clin Endocrinol Metab; 1978 Feb; 46(2):284-94. PubMed ID: 750606
[TBL] [Abstract][Full Text] [Related]
5. Management of disturbed calcium metabolism in uraemic patients: 1. Use of vitamin D metabolites.
Schömig M; Ritz E
Nephrol Dial Transplant; 2000; 15 Suppl 5():18-24. PubMed ID: 11073270
[TBL] [Abstract][Full Text] [Related]
6. Recent advances in our understanding of the vitamin D endocrine system.
De Luca HF
J Lab Clin Med; 1976 Jan; 87(1):7-26. PubMed ID: 173767
[TBL] [Abstract][Full Text] [Related]
7. Recent advances in pediatric metabolic bone disease: the consequences of altered phosphate homeostasis in renal insufficiency and hypophosphatemic vitamin D-resistant rickets.
Pettifor JM
Bone Miner; 1990 Jun; 9(3):199-214. PubMed ID: 2163713
[TBL] [Abstract][Full Text] [Related]
8. Vitamin D: the discovery of its metabolites and their therapeutic applications.
Beale MG; Chan JC; Oldham SB; Deluca HF
Pediatrics; 1976 May; 57(5):729-41. PubMed ID: 181725
[TBL] [Abstract][Full Text] [Related]
9. Vitamin D and the parathyroid.
Beckerman P; Silver J
Am J Med Sci; 1999 Jun; 317(6):363-9. PubMed ID: 10372835
[TBL] [Abstract][Full Text] [Related]
10. [Changes in mineral metabolism in stage 3, 4, and 5 chronic kidney disease (not on dialysis)].
Lorenzo Sellares V; Torregrosa V
Nefrologia; 2008; 28 Suppl 3():67-78. PubMed ID: 19018742
[TBL] [Abstract][Full Text] [Related]
11. Metabolism of vitamin D: current status.
DeLuca HF
Am J Clin Nutr; 1976 Nov; 29(11):1258-70. PubMed ID: 187053
[TBL] [Abstract][Full Text] [Related]
12. Vitamin D retains an important role in the pathogenesis and management of secondary hyperparathyroidism in chronic renal failure.
Cozzolino M; Gallieni M; Brancaccio D; Arcidiacono T; Bianchi G; Vezzoli G
J Nephrol; 2006; 19(5):566-77. PubMed ID: 17136683
[TBL] [Abstract][Full Text] [Related]
13. Advances in vitamin D metabolism as they pertain to chronic renal disease.
Coburn JW; Hartenbower DL; Brickman AS
Am J Clin Nutr; 1976 Nov; 29(11):1283-99. PubMed ID: 187055
[TBL] [Abstract][Full Text] [Related]
14. Insulin secretion in uremia: effect of parathyroid hormone and vitamin D metabolites.
Mak RH
Kidney Int Suppl; 1989 Nov; 27():S227-30. PubMed ID: 2699996
[TBL] [Abstract][Full Text] [Related]
15. The actions of parathyroid hormone on bone: relation to bone remodeling and turnover, calcium homeostasis, and metabolic bone disease. Part IV of IV parts: The state of the bones in uremic hyperaparathyroidism--the mechanisms of skeletal resistance to PTH in renal failure and pseudohypoparathyroidism and the role of PTH in osteoporosis, osteopetrosis, and osteofluorosis.
Parfitt AM
Metabolism; 1976 Oct; 25(10):1157-88. PubMed ID: 787723
[TBL] [Abstract][Full Text] [Related]
16. Vitamin D: recent advances.
DeLuca HF; Schnoes HK
Annu Rev Biochem; 1983; 52():411-39. PubMed ID: 6311080
[TBL] [Abstract][Full Text] [Related]
17. Abnormal expression and regulation of vitamin D receptor in experimental uremia.
Szabó A; Ritz E; Schmidt-Gayk H; Reichel H
Nephron; 1996; 73(4):619-28. PubMed ID: 8856261
[TBL] [Abstract][Full Text] [Related]
18. Calcium and phosphorus metabolism in chronic uremia.
Fiaschi E; Mioni G; Maschio G; D'Angelo A; Ossi E
Nephron; 1975; 14(2):163-80. PubMed ID: 1093055
[TBL] [Abstract][Full Text] [Related]
19. Marked suppression of secondary hyperparathyroidism by intravenous administration of 1,25-dihydroxy-cholecalciferol in uremic patients.
Slatopolsky E; Weerts C; Thielan J; Horst R; Harter H; Martin KJ
J Clin Invest; 1984 Dec; 74(6):2136-43. PubMed ID: 6549016
[TBL] [Abstract][Full Text] [Related]
20. Calreticulin inhibits vitamin D's action on the PTH gene in vitro and may prevent vitamin D's effect in vivo in hypocalcemic rats.
Sela-Brown A; Russell J; Koszewski NJ; Michalak M; Naveh-Many T; Silver J
Mol Endocrinol; 1998 Aug; 12(8):1193-200. PubMed ID: 9717845
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]